ONECUT2 and neoplasm: Our study provides the first evidence that the transcription factor OC2 is a key regulator of tumor cell plasticity and phenotypic heterogeneity allowing adaptation of cells during tumor initiation and progression and driving transitions towards treatment-resistant states.